About - Euroimmun US Company Timeline

A proven history

Euroimmun’s journey began in 1979 with the development of our TITERPLANE® technology, a process that helped standardize immunofluorescence testing by ensuring precise and uniform incubation. Over the following decades, Euroimmun introduced innovative advancements, from BIOCHIP mosaic technology and automated microscopy with EUROPattern to comprehensive ELISA and ChLIA platforms, each setting new benchmarks in precision and efficiency. In 2022, the launch of the UNIQO 160 marked another major milestone in Euroimmun’s evolution, advancing toward fully automated, walkaway IFA (Indirect Immunofluorescence Assay) processing and reinforcing our ongoing commitment to innovation in laboratory diagnostics.

1979

Invention of TITERPLANE technique optimized incubation conditions for IFA

1983

BIOCHIP technology revolutionizes IFA

1987

Founding of EUROIMMUN

1993

First ELISA: Anti-M2 ELISA (Anti-mitochondrial antibodies)

1995

First infectious diseases ELISA: Anti-Borrelia ELISA

1996

EUROPLUS Technology: Multiplex IFA by combining tissue and antigen spots

2002

Anti-CCP ELISA: Breakthrough in rheumatoid arthritis diagnostics

2003

Anti-Borrelia plus VlsE ELISA (IgG): First assay based on recombinant antigen

2005

Analyzer I: First laboratory device

2007

Designer Antigens: Anti-Gliadin (GAF-3X) ELISA with gliadin-analogous fusion peptide

EUROLabOffice: Laboratory Information System

Anti-NMDAR IFA: First recombinant cell (RC) IFA

2009

Nucleosome-mediated coupling of nDNA to the surface of ELISA wells (dsDNA-NcX)

2010

BIOCHIP Mosaics with recombinant cell substances

EUROPattern Microscope: First automated microscope

2011

IFA Automation: Sprinter XL and IF Sprinter

2012

EUROBlotOne: Fully Automated blot device

Milestone in diagnostics of membranous nephropathy: Exclusive anti-phospholipase A2 receptor (PLA2R) assays

2013

Identification of allergy-inducing Components using defined partial allergen diagnostics (DPA-Dx)

EUROArrayScanner

2016

Anti-Zika virus ELISA: Worldwide first CE-marked IVD test

2017

IFA slide washer: MERGITE!

EURLabWorkstation ELISA: Euroimmun’s high-throughput solution for fully automated ELISA processing

2018

EUROArray dermatomycosis: New standard in diagnostics of fungal infections of the skin

2019

EUROLabWorkstation IFA

RA Analyzer 10: First random access device based on ChLIA technology

2020

EURORealTime SARS-CoV-2 and Anti-SARS-CoV-2 ELISA among the first CE-marked assays in Europe for COVID-19 diagnostics

2021

Immunodiagnostic Systems Holding (IDS) was acquired by Revvity, Inc., joining Euroimmun within “Clinical & Diagnostics”.

2022

A breakthrough in IFA automation, the UNIQO 160 integrates every step, from primary sample pipetting to automated IFA image acquisition, into a single, fully automated instrument.

2024

Euroimmun introduces Pattern IQ, an interactive immunofluorescence assay (IFA) training platform that helps laboratory professionals strengthen their pattern recognition skills through education, practice, and assessment.

2025

Euroimmun rebranding – A new design with a new shine

Questions?
We’re here to help.